Breast Cancer
Jan 10, 2025, 14:11
George Vlachogiannis: Breast cancer metastasis to the spleen is a rare event
George Vlachogiannis, Executive Editor of Cancer Control at Sage Publishing, shared a post on LinkedIn:
“Breast cancer metastasis to the spleen is a rare event. Due to this rarity few studies have evaluated clinicopathological characteristics of this patient population. A recent retrospective study published in Cancer Control reports clinicopathological features and prognoses of breast cancer patients with splenic metastases, based on a cohort of ~1,000 patients with metastatic breast cancer.
Spleen metastases were identified in 18 patients (1.7%), were associated with diffuse multiple organ metastases, and with a survival prognosis of less than a year.”
Authors: Xiaofeng Xie et al.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 9, 2025, 15:09
Feb 9, 2025, 15:08
Feb 9, 2025, 15:06
Feb 9, 2025, 15:06
Feb 9, 2025, 15:00
Feb 9, 2025, 14:50